Quarterly Result30 Oct 2026, 06:36 pm
Genomic Valley Biotech declares unaudited Q2 FY27 results
AI Summary
Genomic Valley Biotech Limited announced its unaudited standalone financial results for the quarter and half-year ended September 30, 2026. The Board of Directors approved these results in a meeting held on October 30, 2026. The company has adopted Indian Accounting Standards (Ind AS) and operates within a single business segment, Floriculture. The financial statements were prepared in accordance with applicable Indian Accounting Standards and reviewed by the statutory auditors.
Key Highlights
- Unaudited standalone financial results for Q2 FY27 declared.
- Board of Directors approved the financial results.
- Company operates in the Floriculture segment.
- Financials prepared as per Indian Accounting Standards.
- Statutory auditors have conducted a limited review.
Price Impact
More from GVBL